
Plenary session at CHEST 2013 focused on the impact of early warning scores, medical response teams, availability of critical care attending intensivists, and other quality measures in intensive care.

Plenary session at CHEST 2013 focused on the impact of early warning scores, medical response teams, availability of critical care attending intensivists, and other quality measures in intensive care.

Case study presented at CHEST 2013 details the experience of a patient with hepatitis C who, after undergoing liver transplant, died after developing a serious lung infection and other complications.

Study results presented at CHEST 2013 show that patients given beta-blockers may actually be at increased risk of having an adverse cardiac event during a noncardiac surgical procedure.

A systematic review of 14 randomized controlled trials found a probiotic Lactobacillus strain taken daily lowers the risk of acute upper respiratory tract infection (URTI) without increasing the risk of adverse events.

Citing an increased risk of liver injury observed in recent clinical trials, the US Food and Drug Administration (FDA) has limited Samsca (tolvaptan) treatment to 30 days and recommended the oral selective vasopressin V2-receptor antagonist be discontinued in patients with signs of liver disease or symptoms of liver injury.

As an adjunct to diet and exercise, Amarin's lipid-regulating agent Vascepa (icosapent ethyl capsules) is indicated to reduce triglyceride levels in adult patients with severe hypertriglyceridemia, or very high triglyceride (TG) levels greater than or equal to 500 milligrams per deciliter (mg/dL).

Approved by the FDA nearly four years ago, Otsuka Group's once-daily Samsca (tolvaptan tablets) is indicated to raise serum sodium levels in nonurgent patients with hyponatremia.

During his lecture, Dr. Eli O. Meltzer walked his audience through diagnosis and management guidelines of sinusitis/ rhinosinusitis at the ACAAI annual meeting.

The growing market for home air fresheners is impacting respiratory health, according to Stanley Fineman, MD, MBA, president-elect of ACAAI, associate clinical professor department of pediatrics, Emory University School of Medicine, Atlanta Allergy & Allergy Clinic.

One-fifth of all patients suffering from PAH go undiagnosed and thus untreated for over two years before their disease is correctly identified.

Prescribing antibiotics for patients with discolored phlegm caused by acute cough has little or no effect on alleviating symptoms and recovery.

A significant number of patients with benign prostate enlargement may have obstructive sleep apnea.

Heavy users of marijuana saw a significant decrease in their cravings and daily use after just a few sessions of running on a treadmill.

The FDA has approved Daliresp to reduce the risk of COPD exacerbations in patients with severe COPD.

Data show that rhinovirus and human metapneumovirus are associated with higher pediatric hospitalization rates than influenza.

A new study suggests that only 21% of doctors routinely use spirometry, the guideline-recommended method for assessing lung function.